The Prague Post - First Covid vaccine side-effect claims land in German courts

EUR -
AED 4.105921
AFN 71.553678
ALL 91.669467
AMD 402.546359
ANG 2.00166
AOA 1025.22275
ARS 1700.067271
AUD 1.607953
AWG 2.015227
AZN 1.901008
BAM 1.954083
BBD 2.251891
BDT 137.719012
BGN 1.882117
BHD 0.421624
BIF 3358.049917
BMD 1.118018
BND 1.431343
BOB 13.416329
BRL 5.593776
BSD 1.118003
BTN 108.128557
BWP 15.456421
BYN 3.428888
BYR 21913.14906
BZD 2.248625
CAD 1.593181
CDF 2591.009072
CHF 0.930767
CLF 0.027672
CLP 1092.762094
CNY 7.495859
CNH 7.500055
COP 3626.369025
CRC 510.44472
CUC 1.118018
CUP 26.833427
CVE 110.167232
CZK 24.427789
DJF 199.090645
DKK 7.474642
DOP 67.400788
DZD 150.510896
EGP 58.55484
ERN 16.770267
ETB 181.647121
FJD 2.518668
FKP 0.842078
GBP 0.846592
GEL 2.878897
GGP 0.842078
GHS 13.215567
GIP 0.842078
GMD 82.733608
GNF 9836.358652
GTQ 8.539383
GYD 233.839341
HKD 8.774595
HNL 30.013633
HRK 7.532979
HTG 146.411376
HUF 366.707041
IDR 20009.164731
ILS 3.429688
IMP 0.842078
INR 108.169733
IQD 1464.613321
IRR 1936574.548266
ISK 136.991052
JEP 0.842078
JMD 177.613964
JOD 0.792704
JPY 176.905633
KES 145.230022
KGS 97.76898
KHR 4552.062037
KMF 489.691471
KPW 1006.216384
KRW 1496.981013
KWD 0.347111
KYD 0.931781
KZT 499.774238
LAK 25071.973998
LBP 100121.841873
LKR 369.905034
LRD 191.192036
LSL 18.663553
LTL 3.301216
LVL 0.676278
LYD 7.18269
MAD 11.149805
MDL 19.912507
MGA 4985.620079
MKD 61.515958
MMK 2347.494888
MNT 4021.499564
MOP 9.03806
MRU 44.766272
MUR 52.97208
MVR 17.228871
MWK 1938.722822
MXN 20.221901
MYR 4.572027
MZN 71.436598
NAD 18.663804
NGN 1484.068065
NIO 41.143303
NOK 10.712506
NPR 173.01033
NZD 1.997745
OMR 0.4299
PAB 1.118018
PEN 3.848767
PGK 5.067548
PHP 70.237205
PKR 309.617498
PLN 4.382403
PYG 6523.298385
QAR 4.076337
RON 5.354636
RSD 117.417541
RUB 95.559602
RWF 1651.349272
SAR 4.193522
SBD 9.016859
SCR 15.539263
SDG 672.49389
SEK 11.224071
SGD 1.431393
SHP 0.843501
SLE 27.59209
SLL 23444.265373
SOS 638.938685
SRD 42.093821
STD 23140.711381
STN 24.478167
SVC 9.783318
SYP 14536.467839
SZL 18.657609
THB 37.664338
TJS 10.319634
TMT 3.913062
TND 3.340166
TOP 2.691918
TRY 55.003575
TTD 7.584235
TWD 35.625081
TZS 2962.750581
UAH 50.167527
UGX 4555.936435
USD 1.118018
UYU 44.840206
UZS 13187.296864
VES 975.777602
VND 29046.661692
VUV 134.366078
WST 3.113357
XAF 655.957
XAG 0.018556
XAU 0.000271116777
XCD 3.021499
XCG 2.015003
XDR 0.790497
XOF 655.957
XPF 119.331742
YER 264.103792
ZAR 18.650527
ZMK 10063.494088
ZMW 22.238463
ZWL 360.001278
SSP 6426.076194
MXV 2.285567
  • RELX

    0.3400

    34.37

    +0.99%

  • AZN

    0.5700

    159.18

    +0.36%

  • GSK

    0.3500

    46.95

    +0.75%

  • BP

    -0.0100

    45

    -0.02%

  • BTI

    0.5600

    53.57

    +1.05%

  • RIO

    -2.6200

    93.27

    -2.81%

  • RBGPF

    1.1500

    64.05

    +1.8%

  • RYCEF

    -0.2500

    19

    -1.32%

  • NGG

    -1.5200

    75.33

    -2.02%

  • BCC

    -1.1400

    74.31

    -1.53%

  • VOD

    0.2500

    16.78

    +1.49%

  • JRI

    -0.0550

    10.575

    -0.52%

  • CMSD

    -0.2600

    20.07

    -1.3%

  • BCE

    0.0500

    19.8

    +0.25%

  • CMSC

    -0.0700

    20.05

    -0.35%

First Covid vaccine side-effect claims land in German courts

First Covid vaccine side-effect claims land in German courts

Vaccine-maker BioNTech faced Monday its first legal claim in its home country of Germany over adverse effects allegedly suffered by some users of its Covid vaccines, more than two years after one of the world's fastest and most extensive inoculation campaigns.

Text size:

In the face of the deadly pandemic that emerged in early 2020, which prompted border closures and lockdowns that trapped millions of people in their homes, the arrival of Covid vaccines had been widely hailed as a life-saver.

But the jabs, which had been developed at breakneck speed and granted early approval for usage, are now the focus of legal procedures in several countries including France and Britain where plaintiffs argue that the vaccines harmed their health.

In Germany, a court in Hamburg was prepared to hear a case from Monday against BioNTech, which, together with US giant Pfizer, produced the first mRNA vaccine Comirnaty.

The hearing was delayed however after the claimant's lawyers put in a last-minute challenge of the judge's impartiality, and asking instead for a panel of judges to rule on the case.

In her claim, the plaintiff reported suffering effects including "pain in the upper body, swelling of the extremities, exhaustion, fatigue and sleeping disorders" after receiving the vaccine, the court said.

She is seeking 150,000 euros ($162,000) in damages and recognition that the "defendant is bound to provide material damages", the court added.

Her lawyer Thomas Ulbrich, who is also representing another 250 people in similar cases, said his clients were "all healthy" before suffering from symptoms, allegedly following their jabs.

He believes that the medical files he has on hand offer a link between the vaccines and the symptoms experienced by his clients.

- 'Rocky and long road' -

BioNTech's mRNA vaccine, a scientific breakthrough, had been granted conditional marketing authorisation as early as December 21, 2020, by the EU regulatory authority EMA.

Similar authorisation for Moderna, another mRNA vaccine maker, swiftly followed.

With fears of catching the disease running high, the vaccines were pre-ordered by governments even during their development phases, and deployment swiftly followed once regulatory authorities gave their approval.

But the new generation of inoculations also sparked a wave of vaccine sceptics questioning the safety of the jabs.

Out of 192 million jabs given in Germany, the country's medicines regulator, the Paul Ehrlich Institute, said 338,857 suspected cases of side effects were reported, including 54,879 severe reactions.

Among the worst cases, "the symptoms are very different, they vary from stroke to thrombosis to cardiac diseases", said another German lawyer, Joachim Caesar-Preller, who represents 140 clients making similar claims.

He is seeking up to one million euros in damages per case -- plus interest -- but concedes that a "rocky and long road" lies ahead in the legal battles.

- 'Not an isolated case' -

A key point for the courts is whether the side effects of the medication, when used correctly, surpass "a justifiable level according to the findings of medical science".

In other words, the effects have to be sufficiently serious to be taken into account, said Anatol Dutta, a professor at Munich University.

A claimant identified only as Kathrin K., 45, believes her symptoms are severe enough.

She said she lost a lot of weight after taking the vaccine and had to undergo several intestinal operations.

"I hate it when people tell me that I'm an isolated case," she said. "I'm not."

To address the question of causality, the courts would likely have to obtain expert advice.

Besides the legal avenue, claimants can also turn to the state for compensation for the loss of income.

More than 8,000 such applications had been made as of April, and so far about five percent have been successful, according to German media.

BioNTech told AFP that the number of liability claims made to the company is very small when compared to the number of doses it has delivered worldwide, and that each claim had to be examined individually.

"Justified liability claims would of course be met by BioNTech," it said, adding however that "no causal relationship between (the) health impairments presented and vaccination with Comirnaty has been proven" in the cases it had reviewed so far.

Another lawyer, Anja Dornhoff, advises her clients to establish a chronology and to get medical practitioners to document the development of their symptoms.

"I hope that people with post-vaccination syndromes can be taken seriously," she said.

S.Danek--TPP